NCT06601114View on ClinicalTrials.gov

The Effectiveness of Paracetamol Versus Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Neonates

NAActive, not recruitingINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

October 10, 2024

Study Completion Date

October 10, 2024

Conditions
Patent Ductus Arteriosus in Preterm Infants
Interventions
DRUG

Paracetamol Group

Group A: Paracetamol Group will receive Oral form of paracetamol with dosage of 15mg/kg every 6 hours for 3 days

DRUG

Ibuprofen group

Group B: Ibuprofen Group will receive oral form of ibuprofen at initial dosage of 10mg/kg followed by 5mg/kg after 24 hours and 48 hours.

Trial Locations (1)

25000

MTI, Khyber Teaching Hospital, Peshawar

All Listed Sponsors
lead

Arooj Khan

OTHER

NCT06601114 - The Effectiveness of Paracetamol Versus Ibuprofen in Management of Patent Ductus Arteriosus in Preterm Neonates | Biotech Hunter | Biotech Hunter